NCT00799760 - Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir | Biotech Hunter

Enrollment

541

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2010

Conditions

Gastric Influenza

Interventions

DRUG

oseltamivir + zanamivir

oral oseltamivir 75mg twice daily + zanamivir 10 mg inhaled by mouth twice daily during 5 days

DRUG

oseltamivir + zanamivir's placebo

oral oseltamivir 75mg twice daily+ placebo inhaled by mouth twice daily during 5 day

DRUG

oseltamivir's placebo + zanamivir

oral placebo twice daily + zanamivir 10 mg inhaled by mouth twice daily during 5 day

Trial Locations (1)

Centre Investigateur 155, Deûlémont